BALASIP Trademark

Trademark Overview

On Thursday, June 27, 2019, a trademark application was filed for BALASIP with the United States Patent and Trademark Office. The USPTO has given the BALASIP trademark a serial number of 88491646. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by Arena Pharmaceuticals, Inc.. The BALASIP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use; Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
balasip

General Information

Serial Number88491646
Word MarkBALASIP
Filing DateThursday, June 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use; Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, September 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 2, 2022SOU EXTENSION 4 GRANTED
Thursday, June 2, 2022SOU EXTENSION 4 FILED
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 19, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, March 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, March 19, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, September 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION E-MAILED
Thursday, September 19, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Tuesday, August 13, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, August 8, 2019ASSIGNED TO LIE
Thursday, August 1, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 1, 2019NEW APPLICATION ENTERED

Related Keywords

balasip diseases disorders human preparations pharmaceutical irritable bowel syndrome dermatological autoimmune